Japan Patient Monitoring Market

1      INTRODUCTION

           1.1      REPORT DESCRIPTION

           1.2      RESEARCH METHODOLOGY

                         1.2.1      SECONDARY RESEARCH

                         1.2.2      DATA ANALYSIS FRAMEWORK

                         1.2.3      MARKET SIZE ESTIMATION

                         1.2.4      FORECASTING

                         1.2.5      PRIMARY RESEARCH AND DATA VALIDATION

2      JAPAN PATIENT MONITORING MARKET – EXECUTIVE SUMMARY

           2.1.      MARKET SNAPSHOT, 2023 - 2030, MILLION USD

3      PORTER’S FIVE FORCE MODEL ANALYSIS

           3.1      BARGAINING POWER OF SUPPLIERS

           3.2      BARGAINING POWER OF BUYERS

           3.3      DEGREE OF COMPETITION

           3.4      THREAT OF SUBSTITUTE

           3.5      THREAT OF NEW ENTRANTS

4      MARKET SHARE ANALYSIS

           4.1      MARKET SHARE ANALYSIS OF TOP PROVIDERS, 2023

5      MARKET DYNAMICS

           5.1      GROWTH DRIVERS

                         5.1.1      DRIVER 1

                         5.1.2      DRIVER 2

                         5.1.3      DRIVER 3

                         5.1.4      DRIVER 4

           5.2      CHALLENGES

                         5.2.1      CHALLENGE 1

                         5.2.2      CHALLENGE 2

                         5.2.3      CHALLENGE 3

                         5.2.4      CHALLENGE 4

           5.3      OPPORTUNITIES

                         5.3.1      OPPORTUNITY 1

                         5.3.2      OPPORTUNITY 2

6       JAPAN PATIENT MONITORING MARKET BY PRODUCT

           6.1      OVERVIEW

           6.2      CARDIAC MONITORING DEVICES MARKET

                         6.2.1      MOBILE CARDIAC TELEMETRY MONITORS

                         6.2.2      ELECTROCARDIOGRAM (ECG) DEVICES

                         6.2.3      IMPLANTABLE LOOP RECORDERS

                         6.2.4      EVENT MONITORS

                         6.2.5      SMART/WEARABLE ECG MONITORS

           6.3      BLOOD GLUCOSE MONITORING SYSTEMS MARKET

                         6.3.1      SELF-MONITORING BLOOD GLUCOSE SYSTEMS

                         6.3.2      CONTINUOUS GLUCOSE MONITORING SYSTEMS

           6.4      HEMODYNAMIC/PRESSURE MONITORING DEVICES MARKET

                         6.4.1      HEMODYNAMIC MONITORS

                         6.4.2      BLOOD PRESSURE MONITORS

                         6.4.3      DISPOSABLES

           6.5      MULTI-PARAMETER MONITORING DEVICES MARKET

                         6.5.1      LOW-ACUITY MONITORING DEVICE

                         6.5.2      MID-ACUITY MONITORING DEVICES

                         6.5.3      HIGH-ACUITY MONITORING DEVICES

           6.6      RESPIRATORY MONITORING DEVICES MARKET

                         6.6.1      PULSE OXIMETERS

                         6.6.2      SPIROMETERS

                         6.6.3      CAPNOGRAPHS

                         6.6.4      PEAK FLOW METERS

           6.7      TEMPERATURE MONITORING DEVICE MARKET

                         6.7.1      HANDHELD TEMPERATURE MONITORING DEVICES

                         6.7.2      TABLE-TOP TEMPERATURE MONITORING DEVICES

                         6.7.3      WEARABLE CONTINUOUS MONITORING DEVICES

                         6.7.4      INVASIVE TEMPERATURE MONITORING DEVICES

                         6.7.5      SMART TEMPERATURE MONITORING DEVICES

           6.8      FETAL AND NEONATAL MONITORING DEVICES MARKET

                         6.8.1      NEONATAL MONITORING DEVICES

                         6.8.2      FETAL MONITORING DEVICES

           6.9      NEUROMONITORING DEVICES MARKET

                         6.9.1      ELECTROENCEPHALOGRAPH (EEG) MACHINES

                         6.9.2      ELECTROMYOGRAPHY MACHINES

                         6.9.3      CEREBRAL OXIMETER

                         6.9.4      INTRACRANIAL PRESSURE (ICP) MONITORS

                         6.9.5      MAGNETOENCEPHALOGRAPHY (MEG) MACHINES

                         6.9.6      TRANSCRANIAL DOPPLER (TCD) MACHINES

           6.10      WEIGHT MONITORING DEVICES MARKET

                         6.10.1      DIGITAL

                         6.10.2      ANALOG

           6.11      OTHERS DEVICES MARKET

7       JAPAN PATIENT MONITORING MARKET BY TYPE

           7.1      OVERVIEW

           7.2      CONVENTIONAL MARKET

           7.3      WIRELESS MARKET

8       JAPAN PATIENT MONITORING MARKET BY END USER

           8.1      OVERVIEW

           8.2      HOME HEALTHCARE MARKET

           8.3      HOSPITALS AND CLINICS MARKET

           8.4      OTHERS MARKET

9     COMPANY PROFILES

           9.1     MEDTRONIC PLC

                         9.1.1     COMPANY OVERVIEW

                         9.1.2     COMPANY SNAPSHOT

                         9.1.3     OPERATING BUSINESS SEGMENTS

                         9.1.4     PRODUCT PORTFOLIO

                         9.1.5     BUSINESS PERFORMANCE

                         9.1.6     BUSINESS SEGMENTS

                         9.1.7     GEOGRAPHIC SEGMENTS

                         9.1.8     KEY STRATEGIC MOVES AND DEVELOPMENT

                         9.1.9     PRIMARY MARKET COMPETITORS

           9.2     KONINKLIJKE PHILIPS N.V.

                         9.2.1     COMPANY OVERVIEW

                         9.2.2     COMPANY SNAPSHOT

                         9.2.3     OPERATING BUSINESS SEGMENTS

                         9.2.4     PRODUCT PORTFOLIO

                         9.2.5     BUSINESS PERFORMANCE

                         9.2.6     BUSINESS SEGMENTS

                         9.2.7     GEOGRAPHIC SEGMENTS

                         9.2.8     KEY STRATEGIC MOVES AND DEVELOPMENT

                         9.2.9     PRIMARY MARKET COMPETITORS

           9.3     GE HEALTHCARE

                         9.3.1     COMPANY OVERVIEW

                         9.3.2     COMPANY SNAPSHOT

                         9.3.3     OPERATING BUSINESS SEGMENTS

                         9.3.4     PRODUCT PORTFOLIO

                         9.3.5     BUSINESS PERFORMANCE

                         9.3.6     BUSINESS SEGMENTS

                         9.3.7     GEOGRAPHIC SEGMENTS

                         9.3.8     KEY STRATEGIC MOVES AND DEVELOPMENT

                         9.3.9     PRIMARY MARKET COMPETITORS

           9.4     SIEMENS HEALTHINEERS

                         9.4.1     COMPANY OVERVIEW

                         9.4.2     COMPANY SNAPSHOT

                         9.4.3     OPERATING BUSINESS SEGMENTS

                         9.4.4     PRODUCT PORTFOLIO

                         9.4.5     BUSINESS PERFORMANCE

                         9.4.6     BUSINESS SEGMENTS

                         9.4.7     GEOGRAPHIC SEGMENTS

                         9.4.8     KEY STRATEGIC MOVES AND DEVELOPMENT

                         9.4.9     PRIMARY MARKET COMPETITORS

           9.5     NIHON KOHDEN CORPORATION

                         9.5.1     COMPANY OVERVIEW

                         9.5.2     COMPANY SNAPSHOT

                         9.5.3     OPERATING BUSINESS SEGMENTS

                         9.5.4     PRODUCT PORTFOLIO

                         9.5.5     BUSINESS PERFORMANCE

                         9.5.6     BUSINESS SEGMENTS

                         9.5.7     GEOGRAPHIC SEGMENTS

                         9.5.8     KEY STRATEGIC MOVES AND DEVELOPMENT

                         9.5.9     PRIMARY MARKET COMPETITORS

           9.6     ABBOTT LABORATORIES

                         9.6.1     COMPANY OVERVIEW

                         9.6.2     COMPANY SNAPSHOT

                         9.6.3     OPERATING BUSINESS SEGMENTS

                         9.6.4     PRODUCT PORTFOLIO

                         9.6.5     BUSINESS PERFORMANCE

                         9.6.6     BUSINESS SEGMENTS

                         9.6.7     GEOGRAPHIC SEGMENTS

                         9.6.8     KEY STRATEGIC MOVES AND DEVELOPMENT

                         9.6.9     PRIMARY MARKET COMPETITORS

           9.7     MASIMO CORPORATION

                         9.7.1     COMPANY OVERVIEW

                         9.7.2     COMPANY SNAPSHOT

                         9.7.3     OPERATING BUSINESS SEGMENTS

                         9.7.4     PRODUCT PORTFOLIO

                         9.7.5     BUSINESS PERFORMANCE

                         9.7.6     BUSINESS SEGMENTS

                         9.7.7     GEOGRAPHIC SEGMENTS

                         9.7.8     KEY STRATEGIC MOVES AND DEVELOPMENT

                         9.7.9     PRIMARY MARKET COMPETITORS

           9.8     HILL-ROM HOLDINGS, INC.BIOTRONIK SE AND CO. KG

                         9.8.1     COMPANY OVERVIEW

                         9.8.2     COMPANY SNAPSHOT

                         9.8.3     OPERATING BUSINESS SEGMENTS

                         9.8.4     PRODUCT PORTFOLIO

                         9.8.5     BUSINESS PERFORMANCE

                         9.8.6     BUSINESS SEGMENTS

                         9.8.7     GEOGRAPHIC SEGMENTS

                         9.8.8     KEY STRATEGIC MOVES AND DEVELOPMENT

                         9.8.9     PRIMARY MARKET COMPETITORS

           9.9     BIOTRONIK SE AND CO. KG

                         9.9.1     COMPANY OVERVIEW

                         9.9.2     COMPANY SNAPSHOT

                         9.9.3     OPERATING BUSINESS SEGMENTS

                         9.9.4     PRODUCT PORTFOLIO

                         9.9.5     BUSINESS PERFORMANCE

                         9.9.6     BUSINESS SEGMENTS

                         9.9.7     GEOGRAPHIC SEGMENTS

                         9.9.8     KEY STRATEGIC MOVES AND DEVELOPMENT

                         9.9.9     PRIMARY MARKET COMPETITORS

           9.10     HONEYWELL INTERNATIONAL, INC.

                         9.10.1     COMPANY OVERVIEW

                         9.10.2     COMPANY SNAPSHOT

                         9.10.3     OPERATING BUSINESS SEGMENTS

                         9.10.4     PRODUCT PORTFOLIO

                         9.10.5     BUSINESS PERFORMANCE

                         9.10.6     BUSINESS SEGMENTS

                         9.10.7     GEOGRAPHIC SEGMENTS

                         9.10.8     KEY STRATEGIC MOVES AND DEVELOPMENT

                         9.10.9     PRIMARY MARKET COMPETITORS

LIST OF TABLES

TABLE 1. JAPAN PATIENT MONITORING MARKET VALUE, BY PRODUCT, 2023-2030, (MILLION USD)

TABLE 2. CARDIAC MONITORING DEVICES, MARKET VALUE, 2023-2030, (MILLION USD)

TABLE 3. MOBILE CARDIAC TELEMETRY MONITORS, MARKET VALUE, 2023-2030, (MILLION USD)

TABLE 4. ELECTROCARDIOGRAM (ECG) DEVICES, MARKET VALUE, 2023-2030, (MILLION USD)

TABLE 5. IMPLANTABLE LOOP RECORDERS, MARKET VALUE, 2023-2030, (MILLION USD)

TABLE 6. EVENT MONITORS, MARKET VALUE, 2023-2030, (MILLION USD)

TABLE 7. SMART/WEARABLE ECG MONITORS, MARKET VALUE, 2023-2030, (MILLION USD)

TABLE 8. BLOOD GLUCOSE MONITORING SYSTEMS, MARKET VALUE, 2023-2030, (MILLION USD)

TABLE 9. SELF-MONITORING BLOOD GLUCOSE SYSTEMS, MARKET VALUE, 2023-2030, (MILLION USD)

TABLE 10. CONTINUOUS GLUCOSE MONITORING SYSTEMS, MARKET VALUE, 2023-2030, (MILLION USD)

TABLE 11. HEMODYNAMIC/PRESSURE MONITORING DEVICES, MARKET VALUE, 2023-2030, (MILLION USD)

TABLE 12. HEMODYNAMIC MONITORS, MARKET VALUE, 2023-2030, (MILLION USD)

TABLE 13. BLOOD PRESSURE MONITORS, MARKET VALUE, 2023-2030, (MILLION USD)

TABLE 14. DISPOSABLES, MARKET VALUE, 2023-2030, (MILLION USD)

TABLE 15. MULTI-PARAMETER MONITORING DEVICES, MARKET VALUE, 2023-2030, (MILLION USD)

TABLE 16. LOW-ACUITY MONITORING DEVICE, MARKET VALUE, 2023-2030, (MILLION USD)

TABLE 17. MID-ACUITY MONITORING DEVICES, MARKET VALUE, 2023-2030, (MILLION USD)

TABLE 18. HIGH-ACUITY MONITORING DEVICES, MARKET VALUE, 2023-2030, (MILLION USD)

TABLE 19. RESPIRATORY MONITORING DEVICES, MARKET VALUE, 2023-2030, (MILLION USD)

TABLE 20. PULSE OXIMETERS, MARKET VALUE, 2023-2030, (MILLION USD)

TABLE 21. SPIROMETERS, MARKET VALUE, 2023-2030, (MILLION USD)

TABLE 22. CAPNOGRAPHS, MARKET VALUE, 2023-2030, (MILLION USD)

TABLE 23. PEAK FLOW METERS, MARKET VALUE, 2023-2030, (MILLION USD)

TABLE 24. TEMPERATURE MONITORING DEVICE, MARKET VALUE, 2023-2030, (MILLION USD)

TABLE 25. HANDHELD TEMPERATURE MONITORING DEVICES, MARKET VALUE, 2023-2030, (MILLION USD)

TABLE 26. TABLE-TOP TEMPERATURE MONITORING DEVICES, MARKET VALUE, 2023-2030, (MILLION USD)

TABLE 27. WEARABLE CONTINUOUS MONITORING DEVICES, MARKET VALUE, 2023-2030, (MILLION USD)

TABLE 28. INVASIVE TEMPERATURE MONITORING DEVICES, MARKET VALUE, 2023-2030, (MILLION USD)

TABLE 29. SMART TEMPERATURE MONITORING DEVICES, MARKET VALUE, 2023-2030, (MILLION USD)

TABLE 30. FETAL AND NEONATAL MONITORING DEVICES, MARKET VALUE, 2023-2030, (MILLION USD)

TABLE 31. NEONATAL MONITORING DEVICES, MARKET VALUE, 2023-2030, (MILLION USD)

TABLE 32. FETAL MONITORING DEVICES, MARKET VALUE, 2023-2030, (MILLION USD)

TABLE 33. NEUROMONITORING DEVICES, MARKET VALUE, 2023-2030, (MILLION USD)

TABLE 34. ELECTROENCEPHALOGRAPH (EEG) MACHINES, MARKET VALUE, 2023-2030, (MILLION USD)

TABLE 35. ELECTROMYOGRAPHY MACHINES, MARKET VALUE, 2023-2030, (MILLION USD)

TABLE 36. CEREBRAL OXIMETER, MARKET VALUE, 2023-2030, (MILLION USD)

TABLE 37. INTRACRANIAL PRESSURE (ICP) MONITORS, MARKET VALUE, 2023-2030, (MILLION USD)

TABLE 38. MAGNETOENCEPHALOGRAPHY (MEG) MACHINES, MARKET VALUE, 2023-2030, (MILLION USD)

TABLE 39. TRANSCRANIAL DOPPLER (TCD) MACHINES, MARKET VALUE, 2023-2030, (MILLION USD)

TABLE 40. WEIGHT MONITORING DEVICES, MARKET VALUE, 2023-2030, (MILLION USD)

TABLE 41. DIGITAL, MARKET VALUE, 2023-2030, (MILLION USD)

TABLE 42. ANALOG, MARKET VALUE, 2023-2030, (MILLION USD)

TABLE 43. OTHERS DEVICES, MARKET VALUE, 2023-2030, (MILLION USD)

TABLE 44. JAPAN PATIENT MONITORING MARKET VALUE, BY TYPE, 2023-2030, (MILLION USD)

TABLE 45. CONVENTIONAL, MARKET VALUE, 2023-2030, (MILLION USD)

TABLE 46. WIRELESS, MARKET VALUE, 2023-2030, (MILLION USD)

TABLE 47. JAPAN PATIENT MONITORING MARKET VALUE, BY END USER, 2023-2030, (MILLION USD)

TABLE 48. HOME HEALTHCARE, MARKET VALUE, 2023-2030, (MILLION USD)

TABLE 49. HOSPITALS AND CLINICS, MARKET VALUE, 2023-2030, (MILLION USD)

TABLE 50. OTHERS, MARKET VALUE, 2023-2030, (MILLION USD)

TABLE 51. MEDTRONIC PLC: COMPANY SNAPSHOT

TABLE 52. MEDTRONIC PLC: OPERATING BUSINESS SEGMENTS

TABLE 53. MEDTRONIC PLC: PRODUCT PORTFOLIO

TABLE 54. MEDTRONIC PLC: SALES BY BUSINESS SEGMENTS (2021-2023)

TABLE 55. MEDTRONIC PLC: SALES BY GEOGRAPHIC SEGMENTS (2021-2023)

TABLE 56. MEDTRONIC PLC: KEY STRATERGY

TABLE 57. KONINKLIJKE PHILIPS N.V.: COMPANY SNAPSHOT

TABLE 58. KONINKLIJKE PHILIPS N.V.: OPERATING BUSINESS SEGMENTS

TABLE 59. KONINKLIJKE PHILIPS N.V.: PRODUCT PORTFOLIO

TABLE 60. KONINKLIJKE PHILIPS N.V.: SALES BY BUSINESS SEGMENTS (2021-2023)

TABLE 61. KONINKLIJKE PHILIPS N.V.: SALES BY GEOGRAPHIC SEGMENTS (2021-2023)

TABLE 62. KONINKLIJKE PHILIPS N.V.: KEY STRATERGY

TABLE 63. GE HEALTHCARE: COMPANY SNAPSHOT

TABLE 64. GE HEALTHCARE: OPERATING BUSINESS SEGMENTS

TABLE 65. GE HEALTHCARE: PRODUCT PORTFOLIO

TABLE 66. GE HEALTHCARE: SALES BY BUSINESS SEGMENTS (2021-2023)

TABLE 67. GE HEALTHCARE: SALES BY GEOGRAPHIC SEGMENTS (2021-2023)

TABLE 68. GE HEALTHCARE: KEY STRATERGY

TABLE 69. SIEMENS HEALTHINEERS: COMPANY SNAPSHOT

TABLE 70. SIEMENS HEALTHINEERS: OPERATING BUSINESS SEGMENTS

TABLE 71. SIEMENS HEALTHINEERS: PRODUCT PORTFOLIO

TABLE 72. SIEMENS HEALTHINEERS: SALES BY BUSINESS SEGMENTS (2021-2023)

TABLE 73. SIEMENS HEALTHINEERS: SALES BY GEOGRAPHIC SEGMENTS (2021-2023)

TABLE 74. SIEMENS HEALTHINEERS: KEY STRATERGY

TABLE 75. NIHON KOHDEN CORPORATION: COMPANY SNAPSHOT

TABLE 76. NIHON KOHDEN CORPORATION: OPERATING BUSINESS SEGMENTS

TABLE 77. NIHON KOHDEN CORPORATION: PRODUCT PORTFOLIO

TABLE 78. NIHON KOHDEN CORPORATION: SALES BY BUSINESS SEGMENTS (2021-2023)

TABLE 79. NIHON KOHDEN CORPORATION: SALES BY GEOGRAPHIC SEGMENTS (2021-2023)

TABLE 80. NIHON KOHDEN CORPORATION: KEY STRATERGY

TABLE 81. ABBOTT LABORATORIES: COMPANY SNAPSHOT

TABLE 82. ABBOTT LABORATORIES: OPERATING BUSINESS SEGMENTS

TABLE 83. ABBOTT LABORATORIES: PRODUCT PORTFOLIO

TABLE 84. ABBOTT LABORATORIES: SALES BY BUSINESS SEGMENTS (2021-2023)

TABLE 85. ABBOTT LABORATORIES: SALES BY GEOGRAPHIC SEGMENTS (2021-2023)

TABLE 86. ABBOTT LABORATORIES: KEY STRATERGY

TABLE 87. MASIMO CORPORATION: COMPANY SNAPSHOT

TABLE 88. MASIMO CORPORATION: OPERATING BUSINESS SEGMENTS

TABLE 89. MASIMO CORPORATION: PRODUCT PORTFOLIO

TABLE 90. MASIMO CORPORATION: SALES BY BUSINESS SEGMENTS (2021-2023)

TABLE 91. MASIMO CORPORATION: SALES BY GEOGRAPHIC SEGMENTS (2021-2023)

TABLE 92. MASIMO CORPORATION: KEY STRATERGY

TABLE 93. HILL-ROM HOLDINGS, INC.BIOTRONIK SE AND CO. KG: COMPANY SNAPSHOT

TABLE 94. HILL-ROM HOLDINGS, INC.BIOTRONIK SE AND CO. KG: OPERATING BUSINESS SEGMENTS

TABLE 95. HILL-ROM HOLDINGS, INC.BIOTRONIK SE AND CO. KG: PRODUCT PORTFOLIO

TABLE 96. HILL-ROM HOLDINGS, INC.BIOTRONIK SE AND CO. KG: SALES BY BUSINESS SEGMENTS (2021-2023)

TABLE 97. HILL-ROM HOLDINGS, INC.BIOTRONIK SE AND CO. KG: SALES BY GEOGRAPHIC SEGMENTS (2021-2023)

TABLE 98. HILL-ROM HOLDINGS, INC.BIOTRONIK SE AND CO. KG: KEY STRATERGY

TABLE 99. BIOTRONIK SE AND CO. KG: COMPANY SNAPSHOT

TABLE 100. BIOTRONIK SE AND CO. KG: OPERATING BUSINESS SEGMENTS

TABLE 101. BIOTRONIK SE AND CO. KG: PRODUCT PORTFOLIO

TABLE 102. BIOTRONIK SE AND CO. KG: SALES BY BUSINESS SEGMENTS (2021-2023)

TABLE 103. BIOTRONIK SE AND CO. KG: SALES BY GEOGRAPHIC SEGMENTS (2021-2023)

TABLE 104. BIOTRONIK SE AND CO. KG: KEY STRATERGY

TABLE 105. HONEYWELL INTERNATIONAL, INC.: COMPANY SNAPSHOT

TABLE 106. HONEYWELL INTERNATIONAL, INC.: OPERATING BUSINESS SEGMENTS

TABLE 107. HONEYWELL INTERNATIONAL, INC.: PRODUCT PORTFOLIO

TABLE 108. HONEYWELL INTERNATIONAL, INC.: SALES BY BUSINESS SEGMENTS (2021-2023)

TABLE 109. HONEYWELL INTERNATIONAL, INC.: SALES BY GEOGRAPHIC SEGMENTS (2021-2023)

TABLE 110. HONEYWELL INTERNATIONAL, INC.: KEY STRATERGY

LIST OF FIGURES

FIGURE 1. BARGAINING POWER OF SUPPLIERS

FIGURE 2. BARGAINING POWER OF BUYERS

FIGURE 3. DEGREE OF COMPETITION

FIGURE 4. THREAT OF SUBSTITUTE

FIGURE 5. THREAT OF NEW ENTRANTS

FIGURE 6. JAPAN PATIENT MONITORING MARKET VALUE, BY PRODUCT, 2023-2030, (MILLION USD)

FIGURE 7. CARDIAC MONITORING DEVICES, MARKET VALUE, 2023-2030, (MILLION USD)

FIGURE 8. MOBILE CARDIAC TELEMETRY MONITORS, MARKET VALUE, 2023-2030, (MILLION USD)

FIGURE 9. ELECTROCARDIOGRAM (ECG) DEVICES, MARKET VALUE, 2023-2030, (MILLION USD)

FIGURE 10. IMPLANTABLE LOOP RECORDERS, MARKET VALUE, 2023-2030, (MILLION USD)

FIGURE 11. EVENT MONITORS, MARKET VALUE, 2023-2030, (MILLION USD)

FIGURE 12. SMART/WEARABLE ECG MONITORS, MARKET VALUE, 2023-2030, (MILLION USD)

FIGURE 13. BLOOD GLUCOSE MONITORING SYSTEMS, MARKET VALUE, 2023-2030, (MILLION USD)

FIGURE 14. SELF-MONITORING BLOOD GLUCOSE SYSTEMS, MARKET VALUE, 2023-2030, (MILLION USD)

FIGURE 15. CONTINUOUS GLUCOSE MONITORING SYSTEMS, MARKET VALUE, 2023-2030, (MILLION USD)

FIGURE 16. HEMODYNAMIC/PRESSURE MONITORING DEVICES, MARKET VALUE, 2023-2030, (MILLION USD)

FIGURE 17. HEMODYNAMIC MONITORS, MARKET VALUE, 2023-2030, (MILLION USD)

FIGURE 18. BLOOD PRESSURE MONITORS, MARKET VALUE, 2023-2030, (MILLION USD)

FIGURE 19. DISPOSABLES, MARKET VALUE, 2023-2030, (MILLION USD)

FIGURE 20. MULTI-PARAMETER MONITORING DEVICES, MARKET VALUE, 2023-2030, (MILLION USD)

FIGURE 21. LOW-ACUITY MONITORING DEVICE, MARKET VALUE, 2023-2030, (MILLION USD)

FIGURE 22. MID-ACUITY MONITORING DEVICES, MARKET VALUE, 2023-2030, (MILLION USD)

FIGURE 23. HIGH-ACUITY MONITORING DEVICES, MARKET VALUE, 2023-2030, (MILLION USD)

FIGURE 24. RESPIRATORY MONITORING DEVICES, MARKET VALUE, 2023-2030, (MILLION USD)

FIGURE 25. PULSE OXIMETERS, MARKET VALUE, 2023-2030, (MILLION USD)

FIGURE 26. SPIROMETERS, MARKET VALUE, 2023-2030, (MILLION USD)

FIGURE 27. CAPNOGRAPHS, MARKET VALUE, 2023-2030, (MILLION USD)

FIGURE 28. PEAK FLOW METERS, MARKET VALUE, 2023-2030, (MILLION USD)

FIGURE 29. TEMPERATURE MONITORING DEVICE, MARKET VALUE, 2023-2030, (MILLION USD)

FIGURE 30. HANDHELD TEMPERATURE MONITORING DEVICES, MARKET VALUE, 2023-2030, (MILLION USD)

FIGURE 31. TABLE-TOP TEMPERATURE MONITORING DEVICES, MARKET VALUE, 2023-2030, (MILLION USD)

FIGURE 32. WEARABLE CONTINUOUS MONITORING DEVICES, MARKET VALUE, 2023-2030, (MILLION USD)

FIGURE 33. INVASIVE TEMPERATURE MONITORING DEVICES, MARKET VALUE, 2023-2030, (MILLION USD)

FIGURE 34. SMART TEMPERATURE MONITORING DEVICES, MARKET VALUE, 2023-2030, (MILLION USD)

FIGURE 35. FETAL AND NEONATAL MONITORING DEVICES, MARKET VALUE, 2023-2030, (MILLION USD)

FIGURE 36. NEONATAL MONITORING DEVICES, MARKET VALUE, 2023-2030, (MILLION USD)

FIGURE 37. FETAL MONITORING DEVICES, MARKET VALUE, 2023-2030, (MILLION USD)

FIGURE 38. NEUROMONITORING DEVICES, MARKET VALUE, 2023-2030, (MILLION USD)

FIGURE 39. ELECTROENCEPHALOGRAPH (EEG) MACHINES, MARKET VALUE, 2023-2030, (MILLION USD)

FIGURE 40. ELECTROMYOGRAPHY MACHINES, MARKET VALUE, 2023-2030, (MILLION USD)

FIGURE 41. CEREBRAL OXIMETER, MARKET VALUE, 2023-2030, (MILLION USD)

FIGURE 42. INTRACRANIAL PRESSURE (ICP) MONITORS, MARKET VALUE, 2023-2030, (MILLION USD)

FIGURE 43. MAGNETOENCEPHALOGRAPHY (MEG) MACHINES, MARKET VALUE, 2023-2030, (MILLION USD)

FIGURE 44. TRANSCRANIAL DOPPLER (TCD) MACHINES, MARKET VALUE, 2023-2030, (MILLION USD)

FIGURE 45. WEIGHT MONITORING DEVICES, MARKET VALUE, 2023-2030, (MILLION USD)

FIGURE 46. DIGITAL, MARKET VALUE, 2023-2030, (MILLION USD)

FIGURE 47. ANALOG, MARKET VALUE, 2023-2030, (MILLION USD)

FIGURE 48. OTHERS DEVICES, MARKET VALUE, 2023-2030, (MILLION USD)

FIGURE 49. JAPAN PATIENT MONITORING MARKET VALUE, BY TYPE, 2023-2030, (MILLION USD)

FIGURE 50. CONVENTIONAL, MARKET VALUE, 2023-2030, (MILLION USD)

FIGURE 51. WIRELESS, MARKET VALUE, 2023-2030, (MILLION USD)

FIGURE 52. JAPAN PATIENT MONITORING MARKET VALUE, BY END USER, 2023-2030, (MILLION USD)

FIGURE 53. HOME HEALTHCARE, MARKET VALUE, 2023-2030, (MILLION USD)

FIGURE 54. HOSPITALS AND CLINICS, MARKET VALUE, 2023-2030, (MILLION USD)

FIGURE 55. OTHERS, MARKET VALUE, 2023-2030, (MILLION USD)

FIGURE 56. MEDTRONIC PLC: NET SALES, (2021-2023)

FIGURE 57. MEDTRONIC PLC: PRIMARY MARKET COMPETITORS

FIGURE 58. KONINKLIJKE PHILIPS N.V.: NET SALES, (2021-2023)

FIGURE 59. KONINKLIJKE PHILIPS N.V.: PRIMARY MARKET COMPETITORS

FIGURE 60. GE HEALTHCARE: NET SALES, (2021-2023)

FIGURE 61. GE HEALTHCARE: PRIMARY MARKET COMPETITORS

FIGURE 62. SIEMENS HEALTHINEERS: NET SALES, (2021-2023)

FIGURE 63. SIEMENS HEALTHINEERS: PRIMARY MARKET COMPETITORS

FIGURE 64. NIHON KOHDEN CORPORATION: NET SALES, (2021-2023)

FIGURE 65. NIHON KOHDEN CORPORATION: PRIMARY MARKET COMPETITORS

FIGURE 66. ABBOTT LABORATORIES: NET SALES, (2021-2023)

FIGURE 67. ABBOTT LABORATORIES: PRIMARY MARKET COMPETITORS

FIGURE 68. MASIMO CORPORATION: NET SALES, (2021-2023)

FIGURE 69. MASIMO CORPORATION: PRIMARY MARKET COMPETITORS

FIGURE 70. HILL-ROM HOLDINGS, INC.BIOTRONIK SE AND CO. KG: NET SALES, (2021-2023)

FIGURE 71. HILL-ROM HOLDINGS, INC.BIOTRONIK SE AND CO. KG: PRIMARY MARKET COMPETITORS

FIGURE 72. BIOTRONIK SE AND CO. KG: NET SALES, (2021-2023)

FIGURE 73. BIOTRONIK SE AND CO. KG: PRIMARY MARKET COMPETITORS

FIGURE 74. HONEYWELL INTERNATIONAL, INC.: NET SALES, (2021-2023)

FIGURE 75. HONEYWELL INTERNATIONAL, INC.: PRIMARY MARKET COMPETITOR

 

At Next Move Strategy Consulting, we understand that insightful market research is the cornerstone of successful business decisions. That's why we employ a robust and multifaceted approach, combining various methodologies to deliver the most accurate and actionable data for our clients.

Research Landscape

We navigate the world of research with two primary approaches:

Qualitative Approach

Our qualitative research methodologies involve immersive techniques such as in-depth interviews, focus groups, and observational studies. By engaging directly with individuals and stakeholders, we uncover valuable insights that quantitative data alone may overlook.

Quantitative Research

In tandem with qualitative methodologies, NMSC leverages the power of Quantitative Research to provide a robust foundation of numerical insights. Through systematic data collection and analysis, we quantify patterns, preferences, and market trends, offering a comprehensive view of the business landscape.

Our quantitative research approach employs diverse tools, including surveys, experiments, and statistical modelling. These methodologies enable us to gather data from a large and representative sample, ensuring the statistical significance of our findings. By employing structured questionnaires and standardized data collection methods, we guarantee the reliability and validity of the information we present to our clients.

Quantitative research is particularly effective in measuring the prevalence of trends, assessing market size, and gauging the impact of various factors on consumer behavior. The numerical precision attained through this approach equips our clients with actionable insights, facilitating data-driven decision-making and strategy formulation.

 

Our Specialized Toolbox for Industry-Specific Market Research

We deploy a specialized arsenal of techniques tailored to meet your unique requirements. Here's a glimpse into our comprehensive toolbox:

Information Procurement

The stage entails acquiring market data or relevant information through various sources and methodologies.

Market Research Approach

We utilize both top-down and bottom-up approaches in market research analysis to achieve a comprehensive understanding of the market dynamics, leveraging the broad perspective of industry trends and macroeconomic factors alongside detailed insights from specific segments and individual companies.

Porters Five Forces Analysis

We conduct Porter's Five Forces analysis to evaluate the competitive landscape of an industry, providing us with insights into factors that affect profitability and strategic positioning.

              

SWOT Analysis

We conduct SWOT analysis to understand market trends, identify potential threats, capitalize on opportunities, and assess our strengths and weaknesses.

Forecasting

We utilize a forecasting model to predict future consumption by considering parameters like population, economics, regulations, market competition, drivers, constraints, technology, and pricing. We also employ statistical techniques such as multilinear regression, exponential smoothing, moving average, ARIMA, and Monte Carlo simulations for accurate predictions. In econometric forecasting, we analyzed short-term and long-term event impacts, attributing values based on regulatory frameworks, economic factors, and market events.